Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 Chung Christine SVP, China Operations Sale −4,692 $20.20 $95K 261,964
2023-03-10 Chung Christine SVP, China Operations Sale −2,914 $20.20 $59K 259,050
2023-03-10 Conterno Enrique A Chief Executive Officer Sale −12,103 $20.20 $244K 404,357
2023-03-10 Conterno Enrique A Chief Executive Officer Sale −19,486 $20.20 $394K 384,868
2023-03-10 Eisner Mark Chief Medical Officer Sale −3,885 $20.20 $78K 181,431
2023-03-10 Eisner Mark Chief Medical Officer Sale −6,255 $20.20 $126K 175,176
2023-03-10 Graham Juan Chief Financial Officer Sale −1,112 $20.20 $22K 76,668
2023-03-10 Graham Juan Chief Financial Officer Sale −1,456 $20.20 $29K 75,212
2023-03-10 Graham Juan Chief Financial Officer Sale −2,344 $20.20 $47K 72,868
2023-03-10 Wettig Thane Chief Commercial Officer Sale −2,938 $20.20 $59K 116,289
2023-03-10 Wettig Thane Chief Commercial Officer Sale −4,731 $20.20 $96K 111,558
2023-03-08 Chung Christine SVP, China Operations Sale −8,354 $21.16 $177K 251,519
2023-03-08 Chung Christine SVP, China Operations Grant or award +5,799 257,318
2023-03-08 Chung Christine SVP, China Operations Grant or award +9,338 266,656
2023-03-08 Conterno Enrique A Chief Executive Officer Sale −24,672 $21.16 $522K 356,111
2023-03-08 Conterno Enrique A Chief Executive Officer Grant or award +23,120 379,231
2023-03-08 Conterno Enrique A Chief Executive Officer Grant or award +37,229 416,460
2023-03-08 Eisner Mark Chief Medical Officer Sale −7,363 $21.16 $156K 165,133
2023-03-08 Eisner Mark Chief Medical Officer Grant or award +7,732 172,865
2023-03-08 Eisner Mark Chief Medical Officer Grant or award +12,451 185,316

Page 9 of 16 · 320 trades